SJ733 + Cobicistat
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Malaria
Conditions
Malaria
Trial Timeline
Mar 1, 2016 → Mar 9, 2018
NCT ID
NCT02661373About SJ733 + Cobicistat
SJ733 + Cobicistat is a phase 1 stage product being developed by Eisai for Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT02661373. Target conditions include Malaria.
What happened to similar drugs?
11 of 19 similar drugs in Malaria were approved
Approved (11) Terminated (1) Active (8)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02661373 | Phase 1 | Completed |
Competing Products
20 competing products in Malaria